Form 4 for PYXS Pyxis Oncology, Inc.
Accepted 2023-09-13 00:00:00 ET · period of report 2023-09-11 · accession 0001209191-23-049366 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-09-13 | 2023-09-11+ | PYXS | Sullivan Lara | Pres, CEO, Dir | S - Sale | $2.27 | -27.9K | 2.60M | -1% | -$63.3K |
| 2023-09-13 | 2023-09-13 | PYXS | Sullivan Lara | Pres, CEO, Dir | F - Tax | $2.13 | -184.7K | 2.41M | -7% | -$393.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-13 | S | D | 3,000 | $2.27 | 2,597,265 | D | — | — | (F1) Reflects sales of common stock executed in multiple transactions. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected within the ranges set forth in footnotes 2 through 4 of this Form 4. (F4) The transaction was executed in multiple trades in prices ranging from $2.25 to $2.34. |
| 2 | Common | Common Stock | 2023-09-13 | F | D | 184,742 | $2.13 | 2,412,523 | D | — | — | (F5) Represents shares withheld to cover taxes due upon the vesting of certain restricted stock units. |
| 3 | Common | Common Stock | 2023-09-11 | S | D | 20,000 | $2.27 | 2,605,182 | D | — | — | (F2) The transaction was executed in multiple trades in prices ranging from $2.13 to $2.36. (F1) Reflects sales of common stock executed in multiple transactions. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected within the ranges set forth in footnotes 2 through 4 of this Form 4. |
| 4 | Common | Common Stock | 2023-09-12 | S | D | 4,917 | $2.25 | 2,600,265 | D | — | — | (F1) Reflects sales of common stock executed in multiple transactions. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected within the ranges set forth in footnotes 2 through 4 of this Form 4. (F3) The transaction was executed in multiple trades in prices ranging from $2.21 to $2.30. |